0.40

0.00% 0.00

After Hours: .40

Xtant Medical Holdings Inc (XTNT)

Overview News Price History Discussions Forecast Stock Split

Xtant Medical Holdings Inc stock is traded at $0.40, with a volume of 263.35K. It is up +0.00% in the last 24 hours and down -25.51% over the past month. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.

Previous Close:

$0.40

Open:

$0.415

24h Volume:

263.35K

Relative Volume:

3.34

Market Cap:

$55.60M

Revenue:

$78.46M

Net Income/Loss:

$2.75M

P/E Ratio:

-4.4444

EPS:

-0.09

Net Cash Flow:

$-12.42M

1W Performance:

-2.91%

1M Performance:

-25.51%

6M Performance:

-46.74%

1Y Performance:

-70.37%

1-Day Range:

$0.3981

$0.415

1-Week Range:

$0.3951

$0.4249

52-Week Range:

$0.3931

$1.45

Xtant Medical Holdings Inc Stock (XTNT) Company Profile

Name

Xtant Medical Holdings Inc

Sector

Healthcare (1200)

Industry

Medical Devices (153)

Phone

406-388-0480

Address

664 Cruiser Lane, Belgrade, MT

Employee

174

Twitter

@xtantmedical

Next Earnings Date

2024-11-07

Latest SEC Filings

XTNT's Discussions on Twitter

Compare XTNT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XTNT Xtant Medical Holdings Inc	0.40	55.60M	78.46M	2.75M	-12.42M	-0.09
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-05-23	Initiated	BTIG Research	Buy
Nov-15-18	Reiterated	Maxim Group	Buy
Feb-14-18	Reiterated	Maxim Group	Buy

Xtant Medical Holdings Inc Stock (XTNT) Latest News

Nov 15, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat

Nov 15, 2024

Nov 13, 2024

Earnings call: Xtant Medical announces revenue growth in Q3 2024 - Investing.com

Nov 13, 2024

Xtant Medical Holdings, Inc. (AMEX:XTNT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 12, 2024

Xtant Medical Reports Q3 2024 Revenue Growth and New Product Launches - TipRanks

Nov 12, 2024

Xtant Medical Reports Third Quarter 2024 Financial Results - Yahoo Finance

Nov 12, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat

Nov 12, 2024

Xtant Medical Revenue Surges 36% YTD; Reaffirms Strong 2024 Growth Outlook | XTNT Stock News - StockTitan

Nov 12, 2024

Nov 11, 2024

Xtant Medical to Present at Craig-Hallum Alpha Select Conference: CEO & CFO to Meet Investors | XTNT Stock News - StockTitan

Nov 11, 2024

Earnings To Watch: Xtant Medical Holdings Inc (XTNT) Reports Q3 2024 Result - Yahoo Finance

Nov 11, 2024

Nov 10, 2024

Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024 - WICZ

Nov 10, 2024

Oct 31, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat

Oct 31, 2024

Oct 19, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Oct 19, 2024

Oct 10, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat

Oct 10, 2024

Sep 26, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200 Day Moving Average of $0.00 - MarketBeat

Sep 26, 2024

Sep 24, 2024

Artificial Bone Material Industry Size, Share, Price, Trends, Forecast (2024-2034) - Apiculture Market: Report ...

Sep 24, 2024

Xtra Energy Corp (OTC:XTPT) Stock Gains On Unusual Volume: Here is Why - DRP Journal

Sep 24, 2024

Sep 23, 2024

Market Resilience: XTI Aerospace Inc. (XTIA) Finishes Weak at 0.22, Down -4.06 - The Dwinnex

Sep 23, 2024

Xtant Medical Holdings Inc: Rising -51.55% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle

Sep 23, 2024

When (XTL) Moves Investors should Listen - Stock Traders Daily

Sep 23, 2024

(XSLV) Investment Analysis - Stock Traders Daily

Sep 23, 2024

Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System - PharmiWeb.com

Sep 23, 2024

Sep 22, 2024

Tencent-Backed AI Drug Researcher Xtalpi’s Shares Double On Revenue Rise - Forbes Africa

Sep 22, 2024

Sep 21, 2024

XTX Topco Ltd Buys Shares of 4,012 United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Sep 21, 2024

Sep 18, 2024

Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus - AccessWire

Sep 18, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Stock Crosses Above 200-Day Moving Average of $0.00 - MarketBeat

Sep 18, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Crosses Above 200 Day Moving Average of $0.00 - Defense World

Sep 18, 2024

Sep 10, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above 200-Day Moving Average of $0.00 - MarketBeat

Sep 10, 2024

Sep 01, 2024

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Up 22.4% in August - MarketBeat

Sep 01, 2024

Aug 28, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200-Day Moving Average of $0.00 - MarketBeat

Aug 28, 2024

Aug 18, 2024

Xtant Medical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 - Marketscreener.com

Aug 18, 2024

Aug 16, 2024

Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Passes Above 200 Day Moving Average of $0.00 - Defense World

Aug 16, 2024

Aug 12, 2024

Trading Day Triumph: Xtant Medical Holdings Inc (XTNT) Ends at 0.62, a -4.80 Surge/Plunge - The Dwinnex

Aug 12, 2024

Aug 10, 2024